Bone loss is very common after a bone marrow or stem cell transplant. This presentation discusses what causes bone loss, who’s at risk, and how to prevent and treat it.

After transplant or CAR T-cell therapy, patients often experience a decline in their cognitive abilities, such as finding the right word, multitasking, or completing complex tasks. This presentation explores potential causes of cognitive decline and discusses interventions that can help manage them.

A bone marrow or stem cell transplant can affect the lungs in many ways. This presentation discusses specific lung complications associated with graft-versus-host disease (GVHD) of the lungs, their symptoms, and treatment options.

Liver disease can be a problem after bone marrow or stem cell transplantation. This presentation discusses the major types of liver disease that may arise in these patients, symptoms and available treatments.

This presentation discusses current research on how the intestinal (gut) microbiome impacts patient outcomes following a bone marrow/stem cell transplant or CAR T-cell therapy.

Graft-versus-host-disease (GVHD) can be a major complication after bone marrow/stem cell transplantation. This presentation describes the types of GVHD, its typical effects on patients, and several promising new treatments for this condition.

Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.

This presentation outlines what an autoimmune disease is, current treatment options for these diseases, how autologous transplants are effective in treating specific autoimmune diseases, and the short- and long-term side effects of stem cell transplantation.

Maintenance therapy is now standard of care treatment in newly diagnosed patients with multiple myeloma. This presentation describes what maintenance therapy is, current medications being utilized for maintenance, and what current clinical trials are hoping to reveal.

This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.